Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 91 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR Adding Epcoritamab to Lenalidomide and Rituximab Results in Higher Response Rate and Longer PFS in Patients with Relapsed or Refractory Follicular Lymphoma Patient Guide in Prostate Cancer Now Available in Vietnamese One Dose of Either a Bivalent or Nonavalent HPV Vaccine Provides Protection Against HPV16 or HPV18 Infection and Is Not Inferior To Two Doses MOST POPULAR Study Identifies Potential Drug Target to Prevent Some Liver Cancers February 4, 2022 Efficacy and Safety of FOLFIRI With Durvalumab With or Without Tremelimumab... April 22, 2024 A Chemotherapy-Free Regimen of Tucatinib and Trastuzumab Shows Antitumour Activity with... January 29, 2025 PRO Data Can Help When Deciding Between Neoadjuvant FOLFOX or Fluorouracil-Based... July 10, 2023 Load more HOT NEWS A urine test for bladder cancer: What’s the latest? Can Getting a “Base Tan” Protect You From Sunburn and Skin... Trial Results Highlight Changing Lung Cancer Treatment Landscape 7 images that defined cancer policy in 2022
